Publications

BMC gastroenterology

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

16-08-2019

Nature

Genome-wide cell-free DNA fragmentation in patients with cancer.

01-06-2019

The British journal of radiology

Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

01-05-2019

Endoscopy international open

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients.

01-05-2019

The British journal of surgery

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.

01-04-2019

Cancer

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

15-03-2019

ERJ open research

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.

01-02-2019

Clinical and translational radiation oncology

Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.

01-01-2019

EBioMedicine

Molecular profiling of longitudinally observed small colorectal polyps: A cohort study.

01-01-2019

JCO clinical cancer informatics

American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives.

01-12-2018

The Journal of pathology

Consensus molecular subtype classification of colorectal adenomas.

01-11-2018

BMC cancer

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

20-10-2018

The oncologist

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

01-10-2018

Gastroenterology

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

01-09-2018

Acta oncologica (Stockholm, Sweden)

DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.

01-09-2018

PloS one

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.

04-08-2018

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab.

10-07-2018

Cancer prevention research (Philadelphia, Pa.)

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

01-07-2018

Oncotarget

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

29-06-2018

Scientific reports

Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.

14-05-2018

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

01-04-2018

Gut

Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.

01-03-2018

Acta oncologica (Stockholm, Sweden)

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

01-02-2018

Nuclear medicine communications

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

01-01-2018

Annals of internal medicine

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

19-12-2017

F1000Research

Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.

11-11-2017

Annals of internal medicine

Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.

17-10-2017

Molecular & cellular proteomics : MCP

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.

01-10-2017

Oncotarget

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.

08-09-2017

Nature reviews. Drug discovery

Bridging the translational innovation gap through good biomarker practice.

01-09-2017

Science translational medicine

Direct detection of early-stage cancers using circulating tumor DNA.

16-08-2017

International journal of cancer

Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.

01-08-2017

Virchows Archiv : an international journal of pathology

Early detection: the impact of genomics.

01-08-2017

F1000Research

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.

20-07-2017

PloS one

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.

10-05-2017

International journal of cancer

Assessing opportunities for coordinated R&D in early cancer detection and management in Europe.

01-04-2017

Gastroenterology

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

01-03-2017

BMC cancer

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.

07-02-2017

BMC cancer

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.

07-02-2017

Gut

Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

01-02-2017

British journal of cancer

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

06-12-2016

Oncotarget

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

08-11-2016

Acta oncologica (Stockholm, Sweden)

Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research.

01-11-2016

Clinical cancer research : an official journal of the American Association for Cancer Research

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.

15-09-2016

Oncogene

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

11-08-2016

BMC cancer

A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

21-07-2016

The British journal of radiology

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.

01-07-2016

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.

01-07-2016

Cancer informatics

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.

28-06-2016

Gut

Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps.

01-06-2016

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

Genome-wide cell-free DNA fragmentation in patients with cancer.

Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients.

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.

Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.

Molecular profiling of longitudinally observed small colorectal polyps: A cohort study.

American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond-Lessons Learned and Member Institutions' Perspectives.

Consensus molecular subtype classification of colorectal adenomas.

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.

Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab.

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.

Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.

Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.

Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.

Bridging the translational innovation gap through good biomarker practice.

Direct detection of early-stage cancers using circulating tumor DNA.

Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.

Early detection: the impact of genomics.

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.

Assessing opportunities for coordinated R&D in early cancer detection and management in Europe.

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.

Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research.

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.

CFTR is a tumor suppressor gene in murine and human intestinal cancer.

A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.

Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.

Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps.

This site uses cookies